APVO vs VRTX: Which Stock is Better?

Side-by-side comparison of Aptevo Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

APVO

Aptevo Therapeutics Inc

$4.42

VRTX

Vertex Pharmaceuticals Inc

$469.34

Key Metrics Comparison

MetricAPVOVRTXWinner
Market Cap$6.90M$119.21BVRTX
P/E Ratio0.0030.68APVO
EPS (TTM)$7758.20$15.30APVO
Revenue Growth-1.0%0.1%VRTX
Gross Margin0.0%53.7%VRTX

Analyze APVO

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is APVO or VRTX a better investment?

Comparing APVO and VRTX: Aptevo Therapeutics Inc has a market cap of $6.90M while Vertex Pharmaceuticals Inc has $119.21B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between APVO and VRTX?

APVO (Aptevo Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: APVO or VRTX?

Based on P/E ratios, APVO trades at a lower multiple (0.0x vs 30.7x).

Which is growing faster: APVO or VRTX?

VRTX has higher revenue growth at 0.1% vs -1.0% for APVO.

Which company is more profitable: APVO or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for APVO.

Which is the larger company: APVO or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $119.21B compared to $6.90M for APVO.

Should I buy APVO or VRTX in 2026?

Both APVO and VRTX have investment merit. APVO trades at $4.42 while VRTX trades at $469.34. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between APVO and VRTX stock?

Key differences: Market Cap ($6.90M vs $119.21B), P/E Ratio (0.0x vs 30.7x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).

Popular Stock Comparisons